Gastric cancer
Conditions
Interventions
Experimental group:All research participants underwent enhanced CT and perfluorobutane microbubble ultrasound imaging.
Sponsors
Shandong First Medical University First Affiliated Hospital (Shandong Qianfoshan Hospital)
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Able to understand and voluntarily sign a written informed consent form, which must be signed before the designated research procedures required for the study are performed. Able to understand and voluntarily sign a written informed consent form, which must be signed before the designated research procedures required for the study are performed. 2. Aged >= 18 years and = 6 months. 7. Able to cooperate with the implementation of this protocol.
Exclusion criteria
Exclusion criteria: 1. Evidence of distant organ metastasis exists. 2. There is clinically symptomatic cancerous pleural effusion, pericardial effusion, or ascites requiring frequent drainage. 3. A history of other malignant tumors. 4. Poor nutritional status, BMI 2), such as severe pneumonia, bacteremia, and infectious complications requiring hospitalization; active pulmonary inflammation based on baseline chest X-ray; infections requiring oral or IV antibiotic treatment occurring within 14 days prior to the first dose (excluding prophylactic antibiotic use). 8. Patients with a history of active tuberculosis infection or CT imaging showing active tuberculosis; or patients with a history of active tuberculosis infection within the past year; or patients with active tuberculosis infection who have not received systemic treatment for over a year. 9. The presence of active hepatitis B (HBV DNA >= 2000 IU/mL or 10^4 copies/mL) or hepatitis C (positive for hepatitis C antibody, HCV RNA above detection limit). 10. Known active syphilis infection. 11. Women who are pregnant or breastfeeding. 12. Currently participating in another clinical study, as well as other factors judged by the investigator that may lead to the participant being forced to withdraw from the study, such as other severe diseases needing simultaneous treatment (including mental health issues), alcohol abuse, drug misuse, and family or social factors that may affect the safety or compliance of the study participants.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Enhanced CT and perfluorobutane microbubble ultrasound imaging improve the accuracy of N staging diagnosis.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Perfluorobutane microsphere lymph node imaging time; | — |
Countries
China
Contacts
Public ContactZhang Guangyong
Shandong First Medical University First Affiliated Hospital (Shandong Qianfoshan Hospital)
Outcome results
None listed